Premium
Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes
Author(s) -
Douglas Pauline H.,
Block Peter C.
Publication year - 2000
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/1522-726x(200007)50:3<352::aid-ccd19>3.0.co;2-0
Subject(s) - medicine , prolongation , qt interval , haloperidol , cardiology , ventricular fibrillation , anesthesia , atrial fibrillation , long qt syndrome , dopamine
We report on three patients with acute coronary syndromes who developed QT interval prolongation associated with intravenous haloperidol use. One developed ventricular fibrillation. We also review 21 such patients from the literature. Haloperidol should be used with caution and QT intervals monitored closely in patients with coronary ischemia who may be prone to ventricular ectopy. Cathet. Cardiovasc. Intervent. 50:352–355, 2000. © 2000 Wiley‐Liss, Inc.